AR071586A1 - Tienopirimidinas - Google Patents
TienopirimidinasInfo
- Publication number
- AR071586A1 AR071586A1 ARP090101244A ARP090101244A AR071586A1 AR 071586 A1 AR071586 A1 AR 071586A1 AR P090101244 A ARP090101244 A AR P090101244A AR P090101244 A ARP090101244 A AR P090101244A AR 071586 A1 AR071586 A1 AR 071586A1
- Authority
- AR
- Argentina
- Prior art keywords
- hal
- mono
- trisubstituted
- atoms
- alko
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Las tienopirimidinas de la formula 1 en donde R1 es benzofuranilo, benzotiazolilo, benzotiofenilo, imidazo[1,2a)piridina, quinolinilo, isoquinolinilo o furanilo no sustituido o mono-, di- o trisustituido con A y/o Hal, o piridinilo mono-, di- o trisustituido con A y/o Hal, R2 es H, Alk, Het1, Cyc, AlkNH2, AlkNHA, AlkNAA', AlkOH, AlkOA, AlkCyc, AlkHet1, AlkOAlkOH, AlkO(CH2)mNAA', AlkCHOH(CH2)mOH, AlkO(CH2)mHet1, AlkAr o AlkO(CH2)mAr, X es un enlace simple, NH, S o SO2, Alk es alquileno o alquinilo C1-6, en donde 1 a 4 átomos de H pueden estar sustituidos con F, Cl, Br y/o CN, Cyc es cicloalquilo C3-7, en donde 1 a 4 átomos de H pueden estar reemplazados por A, Hal, OH y/u OA; Het1 es un heterociclo saturado, insaturado o aromático mono- o bicíclico con 1 a 4 átomos de N, O y/o S, que puede estar mono-, di- o trisustituido con A, OH, OA, Hal, SO2A y/u =O (oxígeno del carbonilo), Ar es fenilo, que no está sustituido o que está mono-, di- o trisustituido con A, OH, OA, Hal, SO2NH2, SO2NA y/o SO2NAA', A, A' son en cada caso, de modo independiente entre sí, alquilo no ramificado o ramificado C1-10, en donde uno, dos o tres grupos CH2 que pueden estar reemplazados, de modo independiente entre sí, por grupos -CH=CH- y/o -C:::C- y/o 1-5 átomos de H pueden estar reemplazados por F, Cl y/o Br, Hal es F, Cl, Br o I, m es 1,2, 3 o 4, así como sus derivados, sales, solvatos, tautomeros y estereoisomeros farmacéuticamente aceptables, incluyendo sus mezclas en todas las proporciones, procedimiento de preparacion, composicion farmacéutica y uso como inhibidores de la quinasa del receptor TGF-beta, y se pueden emplear, por ejemplo, para el tratamiento de tumores.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008017853A DE102008017853A1 (de) | 2008-04-09 | 2008-04-09 | Thienopyrimidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR071586A1 true AR071586A1 (es) | 2010-06-30 |
Family
ID=40765631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090101244A AR071586A1 (es) | 2008-04-09 | 2009-04-08 | Tienopirimidinas |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110028472A1 (es) |
| EP (1) | EP2260044A2 (es) |
| JP (1) | JP2011518132A (es) |
| KR (1) | KR20110010721A (es) |
| CN (1) | CN102015724A (es) |
| AR (1) | AR071586A1 (es) |
| AU (1) | AU2009235729A1 (es) |
| BR (1) | BRPI0911364A2 (es) |
| CA (1) | CA2720878A1 (es) |
| DE (1) | DE102008017853A1 (es) |
| EA (1) | EA201001576A1 (es) |
| IL (1) | IL208066A0 (es) |
| MX (1) | MX2010011015A (es) |
| WO (1) | WO2009124653A2 (es) |
| ZA (1) | ZA201007979B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010149257A1 (en) * | 2009-06-22 | 2010-12-29 | Merck Patent Gmbh | Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators |
| WO2011051342A1 (en) | 2009-10-30 | 2011-05-05 | Janssen Pharmaceutica Nv | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| SG182803A1 (en) | 2010-02-05 | 2012-09-27 | Merck Patent Gmbh | Hetaryl-[1,8]naphthyridine derivatives |
| EA022064B1 (ru) | 2010-02-22 | 2015-10-30 | Мерк Патент Гмбх | Гетариламинонафтиридины в качестве ингибиторов атф-связывающих белков |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| EP2723744B1 (en) | 2011-06-27 | 2016-03-23 | Janssen Pharmaceutica, N.V. | 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES |
| FR2988722B1 (fr) | 2012-04-03 | 2014-05-09 | Sanofi Sa | Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques |
| US9669035B2 (en) | 2012-06-26 | 2017-06-06 | Janssen Pharmaceutica Nv | Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders |
| WO2014009305A1 (en) | 2012-07-09 | 2014-01-16 | Janssen Pharmaceutica Nv | Inhibitors of phosphodiesterase 10 enzyme |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| EP1187633A4 (en) | 1999-04-08 | 2005-05-11 | Arch Dev Corp | USE OF ANTI-VEGF ANTIBODY FOR INCREASING IRRADIATION IN CANCER THERAPY |
| JPWO2005080377A1 (ja) * | 2004-02-20 | 2007-10-25 | キリンホールディングス株式会社 | ＴＧＦβ阻害活性を有する化合物およびそれを含んでなる医薬組成物 |
| WO2006090094A1 (en) * | 2005-02-28 | 2006-08-31 | Vernalis R & D Ltd | Pyrimidothiophene compounds for use as hsp90 inhibitors |
| DE102005013621A1 (de) * | 2005-03-24 | 2006-09-28 | Curacyte Discovery Gmbh | Substituierte 2-Aryl(Hetaryl)-5-aminothieno[2,3-d]pyrimidin-6-carbonsäureamide, Verfahren zu ihrer Herstellung und Verwendung als Pharmazeutika |
| CA2637245A1 (en) | 2006-01-17 | 2007-07-26 | Signal Pharmaceuticals, Llc | Inhibitors of tnf.alpha., pde4 and b-raf, compositions thereof and methods of use therewith |
| JPWO2008020622A1 (ja) * | 2006-08-17 | 2010-01-07 | 杏林製薬株式会社 | 新規なチエノ［２，３−ｄ］ピリミジン化合物 |
-
2008
- 2008-04-09 DE DE102008017853A patent/DE102008017853A1/de not_active Withdrawn
-
2009
- 2009-03-23 WO PCT/EP2009/002112 patent/WO2009124653A2/de active Application Filing
- 2009-03-23 JP JP2011503357A patent/JP2011518132A/ja active Pending
- 2009-03-23 EA EA201001576A patent/EA201001576A1/ru unknown
- 2009-03-23 EP EP09731280A patent/EP2260044A2/de not_active Withdrawn
- 2009-03-23 AU AU2009235729A patent/AU2009235729A1/en not_active Abandoned
- 2009-03-23 CA CA2720878A patent/CA2720878A1/en not_active Abandoned
- 2009-03-23 MX MX2010011015A patent/MX2010011015A/es not_active Application Discontinuation
- 2009-03-23 US US12/937,031 patent/US20110028472A1/en not_active Abandoned
- 2009-03-23 KR KR1020107025024A patent/KR20110010721A/ko not_active Application Discontinuation
- 2009-03-23 BR BRPI0911364A patent/BRPI0911364A2/pt not_active Application Discontinuation
- 2009-03-23 CN CN2009801122450A patent/CN102015724A/zh active Pending
- 2009-04-08 AR ARP090101244A patent/AR071586A1/es unknown
-
2010
- 2010-09-07 IL IL208066A patent/IL208066A0/en unknown
- 2010-11-08 ZA ZA2010/07979A patent/ZA201007979B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201001576A1 (ru) | 2011-04-29 |
| IL208066A0 (en) | 2010-12-30 |
| CN102015724A (zh) | 2011-04-13 |
| WO2009124653A2 (de) | 2009-10-15 |
| US20110028472A1 (en) | 2011-02-03 |
| EP2260044A2 (de) | 2010-12-15 |
| BRPI0911364A2 (pt) | 2015-12-29 |
| ZA201007979B (en) | 2011-07-27 |
| KR20110010721A (ko) | 2011-02-07 |
| AU2009235729A1 (en) | 2009-10-15 |
| JP2011518132A (ja) | 2011-06-23 |
| CA2720878A1 (en) | 2009-10-15 |
| DE102008017853A1 (de) | 2009-10-15 |
| MX2010011015A (es) | 2010-11-22 |
| WO2009124653A3 (de) | 2009-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR071586A1 (es) | Tienopirimidinas | |
| AR082109A1 (es) | Derivados de bipiridilo | |
| AR068658A1 (es) | Derivados de tiazol | |
| AR074418A1 (es) | Compuestos de benzonaftiridina, procedimiento de preparacion y su uso en el tratamiento de tumores | |
| AR085637A1 (es) | Derivados de pirido[2,3-b]pirazina | |
| AR058205A1 (es) | 5-fenil-3,6-dihidro-2-oxo-6h-[1,3,4] tiadiazinas sustituidas | |
| AR090602A1 (es) | AMIDAS CICLICAS Y HETEROCICLOS COMO INHIBIDORES DE MetAP-2 | |
| AR067757A1 (es) | Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales. | |
| AR051623A1 (es) | Derivados de piridopirimidinona | |
| AR077567A1 (es) | Derivados de aminopiridina | |
| AR066543A1 (es) | Derivados de piridazinona | |
| AR059908A1 (es) | Derivados de 4-(pirrolopiridinil)-pirimidinil-2-amina | |
| AR055376A1 (es) | Derivados de 1-acildihidropirazol | |
| AR089945A1 (es) | DERIVADOS DE FURO[3,2-B] Y TIENO[3,2-B]PIRIDINA COMO MODULADORES DE TBK1 E IKKe | |
| AR094982A1 (es) | Derivados de triazolo[4,5-d]pirimidina | |
| AR094981A1 (es) | Derivados de imidazopirimidinas | |
| AR089944A1 (es) | Derivados de tetrahidro-quinazolinona | |
| AR071208A1 (es) | Derivados de piridazinona | |
| AR068872A1 (es) | 5- ciano- tienopiridinas. procesos de obtencion y composiciones farmaceuticas. | |
| AR096235A1 (es) | Arilquinazolinas | |
| AR077488A1 (es) | Compuestos heterociclicos nitrogenados inhibidores de autotaxina, medicamentos que los contienen y uso de los mismos para el tratamiento y/o prevencion de cancer y enfermedades tumorales. | |
| ECSP12011691A (es) | Compuestos de urea que contienen heteroarilo 5,6-bicíclicos como inhibidores de quinasa | |
| AR073055A1 (es) | Derivados biciclicos de triazol | |
| AR067081A1 (es) | Derivados de pirrolo[2,3-b]piridin-pirimidina,proceso de preparacion, medicamentos que los contienen y usos de los mismos para el tratamiento de tumores cancerigenos y metastasis tumorales. | |
| AR092924A1 (es) | Derivados de pirrolidinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |